Results 101 to 110 of about 897 (148)

[Guidelines for iron chelation therapy in thalassemia in China (2025)]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi
Committee of Thalassemia Prevention and Treatment   +6 more
europepmc   +1 more source

[Guideline for transfusion management in Chinese children with transfusion-dependent thalassemia (2025)]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi
Committee of Thalassemia Prevention and Treatment   +6 more
europepmc   +1 more source

[Delayed physical growth and related factors in pediatric patients with transfusion-dependent thalassemia]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Kuang ZX   +15 more
europepmc   +1 more source

[Clinical characteristics of cytokine release syndrome after haploidentical hematopoietic stem cell transplantation for thalassemia major]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi
Zhou XH   +9 more
europepmc   +1 more source

脐带血、新生儿外周血混合移植治疗1 例重型β-地中海贫血

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2001
【目的】观察脐带血、新生儿外周血混合的造血干细胞移植治疗1 例重型β-地中海贫血的疗效和副作用。【方 法】采集1 例产前HLA 配型相合男性(XY)胎儿的脐带血53 mL, 并于供者娩出后5 h 内抽取未作任何药物“ 动员” 的新生儿 外周血28 mL。测定脐带血、新生儿外周血的各项造血指标。重型β-地中海贫血女性(XX)患儿经总量马利兰20 mg/ kg , 环 磷酰胺200 mg/ kg , 马法兰90 mg/m2 和抗胸腺淋巴细胞球蛋白90 mg/ kg 组成的方案预处理后, 输入HLA ...
doaj  

[Multiple myeloma with massive proliferation of signet ring cell like plasma cells: a case report]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Bai ZY   +6 more
europepmc   +1 more source

非强效卵巢刺激的地中海贫血患者胚胎种植前遗传学 诊断助孕治疗结局

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2014
摘 要:【目的】 观察非强效卵巢刺激的地中海盆血(地贫)患者胚胎种植前遗传学诊断助孕治疗结局,探讨特殊助孕目的下地贫患者卵巢反应性及合适的刺激强度?【方法】 收集70名因地中海贫血行胚胎种植前遗传学诊断治疗(实验组)及57名因男方因素行单精子卵胞浆内注射患者(对照组),比较其在同等强度刺激下的卵巢反应及临床结局?【结果】 在基础内分泌水平及卵巢刺激强度可比情况下,实验组可移植胚胎数显著少于对照组,差异具有统计学意义(P=0.021);两组患者的获卵数?临床妊娠率?每移植周期活产率均没有统计学差异 ...
doaj  

[Chinese guideline on the diagnosis and treatment of adult primary immune thrombocytopenia (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Thrombosis and Hemostasis Group   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy